Skip to main content

DISEÑO, SINTESIS Y VALIDACION DE SONDAS DIRIGIDAS AL METABOLISMO Y FUNCIONES DE LOS ESFINGOLIPIDOS

CTQ2014-54743-R

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2014
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Secretaría de Estado de Educación, Formación Profesional y Universidades
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

3-Ketosphinganine provokes the accumulation of dihydroshingolipids and induces autophagy in cancer cells.

  • Ordóñez, Yadira F.
  • González, Jèssica
  • Bedia, Carmen
  • Casas, Josefina
  • Abad, José Luis
  • Delgado Cirilo, Antonio
  • Fabriàs, Gemma
Although several reports describe the metabolic fate of sphingoid bases and their analogs, as well as their action and that of their phosphates as regulators of sphingolipid metabolizing-enzymes, similar studies for 3-ketosphinganine (KSa), the product of the first committed step in de novo sphingolipid biosynthesis, have not been reported. In this article we show that 3-ketosphinganine (KSa) and its dideuterated analog at C4 (d2KSa) are metabolized to produce high levels of dihydrosphingolipids in HGC27, T98G and U87MG cancer cells. In contrast, either direct C1 O-phosphorylation or N-acylation of d2KSa to produce dideuterated ketodihydrosphingolipids does not occur. We also show that cells respond to d2KSa treatment with induction of autophagy. Time-course experiments agree with sphinganine, sphinganine 1-phosphate and dihydroceramides being the mediators of autophagy stimulated by d2KSa. Enzyme inhibition studies support that inhibition of Des1 by 3-ketobases is caused by their dihydroceramide metabolites. However, this effect contributes to increasing dihydrosphingolipid levels only at short incubation times, since cells respond to long time exposure to 3-ketobases with Des1 overexpression. The translation of these overall effects into cell fate is discussed., Partial financial support from the ‘‘Ministerio de Ciencia e Innovación’’, Spain (Grants SAF2011-22444), ‘‘Ministerio de Economía y Competitividad’’ (CTQ2014-54743-R), CSIC (Grant PIE 2008801034) and Fundacio´ La Marato´ TV3 (Grant 112130 and 112132) is acknowledged. A PhD fellowship from SENESCYTEcuador to Y. F. O. is also acknowledged. We thank Pedro Rayo for his excellent technical assistance., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Acid Ceramidase Deficiency in Mice Results in a Broad Range of Central Nervous System Abnormalities

  • Sikora, Jakub
  • Casas, Josefina
  • Fabriàs, Gemma
  • Walkley, Steven U.
arber disease is a rare autosomal recessive disorder caused by acid ceramidase deficiency that usually presents as early-onset progressive visceral and neurologic disease. To understand the neurologic abnormality, we investigated behavioral, biochemical, and cellular abnormalities in the central nervous system of Asah1P361R/P361R mice, which serve as a model of Farber disease. Behaviorally, the mutant mice had reduced voluntary locomotion and exploration, increased thigmotaxis, abnormal spectra of basic behavioral activities, impaired muscle grip strength, and defects in motor coordination. A few mutant mice developed hydrocephalus. Mass spectrometry revealed elevations of ceramides, hydroxy-ceramides, dihydroceramides, sphingosine, dihexosylceramides, and monosialodihexosylganglioside in the brain. The highest accumulation was in hydroxy-ceramides. Storage compound distribution was analyzed by mass spectrometry imaging and morphologic analyses and revealed involvement of a wide range of central nervous system cell types (eg, neurons, endothelial cells, and choroid plexus cells), most notably microglia and/or macrophages. Coalescing and mostly perivascular granuloma–like accumulations of storage-laden CD68+ microglia and/or macrophages were seen as early as 3 weeks of age and located preferentially in white matter, periventricular zones, and meninges. Neurodegeneration was also evident in specific cerebral areas in late disease. Overall, our central nervous system studies in Asah1P361R/P361R mice substantially extend the understanding of human Farber disease and suggest that this model can be used to advance therapeutic approaches for this currently untreatable disorder. © 2017 American Society for Investigative Pathology, Supported by National Institute of Neurological Diseases and Stroke Award 1F05 NS074790, Charles University Research Development Schemes (PRVOUK) grant P24/LF1/3, and OPPK grant CZ.2.16/3.1.00/24509 (J.S.); the Canadian Institutes of Health Research Biological Therapeutics Traineeship (S.D.); NIH grants 1R21NS078191-01A1 (J.A.M.), R01 HD045561 (S.U.W.), and P30 HD071593 (S.U.W.); Spanish Ministries of Science and Technology grant SAF2011-22444 and Economy and Competitiveness grant CTQ2014-54743-R (J.C. and G.F.); INSERM (T.L.); Vaincre les Maladies Lysosomales (T.L. and J.A.M.); and the South Carolina SmartState Endowed Research program, National Cancer Institute grant P30 CA138313 and South Carolina Clinical and Translational Research Institute grants UL1 RR029882 and UL1 TR000062 (R.R.D.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Activity of neutral and alkaline ceramidases on fluorogenic N -acylated coumarin-containing aminodiols

  • Casasampere, Mireia
  • Camacho, Luz
  • Casas, Josefina
  • Cingolani, Francesca
  • Egido-Gabás, Meritxell
  • Abad, José Luis
  • Bedia, Carmen
  • Fabriàs, Gemma
Ceramidases catalyze the cleavage of ceramides into sphingosine and fatty acids. Previously, we reported on the use of the RBM14 fluorogenic ceramide analogs to determine acidic ceramidase activity. In this work, we investigated the activity of other amidohydrolases on RBM14 compounds. Both bacterial and human purified neutral ceramidases (NCs), as well as ectopically expressed mouse neutral ceramidase hydrolyzed RBM14 with different selectivity, depending on the N -acyl chain length. On the other hand, microsomes from alkaline ceramidase (ACER)3 knockdown cells were less competent at hydrolyzing RBM14C12, RBM12C14, and RBM14C16 than controls, while microsomes from ACER2 and ACER3 overexpressing cells showed no activity toward the RBM14 substrates. Conversely, N -acylethanolamine-hydrolyzing acid amidase (NAAA) overexpressing cells hydrolyzed RBM14C14 and RBM14C16 at acidic pH. Overall, NC, ACER3, and, to a lesser extent, NAAA hydrolyze fluorogenic RBM14 compounds. Although the selectivity of the substrates toward ceramidases can be modulated by the length of the N -acyl chain, none of them was specific for a particular enzyme. Despite the lack of specificity, these substrates should prove useful in library screening programs aimed at identifying potent and selective inhibitors for NC and ACER3. Copyright © 2015 by the American Society for Biochemistry and Molecular Biology, Inc., This work was supported, in whole or in part, by the Spanish Ministry of Economy and Competitiveness (Grants SAF2011-22444 and CTQ2014-54743-R to G.F.), the Fundació la Marató de TV3 (Grants 112130 to J.C. and 112132), Agència de Gestió d’Ajuts Universitaris i de Recerca of Generalitat de Catalunya (Grant 2009SGR1072 to G.F.), National Cancer Institute (Grant NCI PO1 97132 to Y.A.H.), and National Institutes of Health (Grant R01CA163825 to C.M.). L.C. and F.C. were supported by predoctoral fellowships and C.B. was supported by postdoctoral contracts awarded by the Generalitat de Catalunya., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Activity-Based Imaging of Acid Ceramidase in Living Cells

  • Ordóñez, Yadira F.
  • Abad, José Luis
  • Aseeri, Mazen
  • Casas, Josefina
  • Garcia, Virginie
  • Casasampere, Mireia
  • Schuchman, Edward H.
  • Levade, Thierry
  • Delgado Cirilo, Antonio
  • Triola Guillem, Gemma
  • Fabriàs, Gemma
Acid ceramidase (AC) hydrolyzes ceramides into sphingoid bases and fatty acids. The enzyme is overexpressed in several types of cancer and Alzheimer’s disease, and its genetic defect causes different incurable disorders. The availability of a method for the specific visualization of catalytically active AC in intracellular compartments is crucial for diagnosis and follow-up of therapeutic strategies in diseases linked to altered AC activity. This work was undertaken to develop activity-based probes for the detection of AC. Several analogues of the AC inhibitor SABRAC were synthesized and found to act as very potent (two-digit nM range) irreversible AC inhibitors by reaction with the active site Cys143. Detection of active AC in cell-free systems was achieved either by using fluorescent SABRAC analogues or by click chemistry with an azide-substituted analogue. The compound affording the best features allowed the unprecedented labeling of active AC in living cells., We thank Prof. H. Overkleeft and Dr. C. Ouairy (Leiden Institute of Chemistry) for a kind gift of BODIPY-carmofur, as well as A. Garcia (IQAC–CSIC), P. Rayo (IQAC–CSIC), I. Pérez-Pomeda (IQAC–CSIC), E. Dalmau (IQAC–CSIC), and Dr. M. Bosch (CCiT-UB) for their excellent technical assistance. This work has been partly funded by the Spanish Ministry of Economy, Industry and Competitiveness (Grants CTQ2014-54743-R, CTQ-2013-44334-P, and CTQ2017-85378-R)., Peer reviewed